• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

隐匿性乙型肝炎:临床观点与管理

Occult hepatitis B: clinical viewpoint and management.

作者信息

Zobeiri Mehdi

机构信息

Internal Medicine Department, Imam Reza Hospital, Kermanshah University of Medical Sciences, Kermanshah, Iran.

出版信息

Hepat Res Treat. 2013;2013:259148. doi: 10.1155/2013/259148. Epub 2013 Mar 4.

DOI:10.1155/2013/259148
PMID:23533738
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3603201/
Abstract

Occult HBV infection (OBI) is defined as HBV DNA detection in serum or in the liver by sensitive diagnostic tests in HBsAg-negative patients with or without serologic markers of previous viral exposure. OBI seems to be higher among subjects at high risk for HBV infection and with liver disease. OBI can be both a source of virus contamination in blood and organ donations and the reservoir for full blown hepatitis after reactivation. HBV reactivation depends on viral and host factors but these associations have not been analyzed thoroughly. In OBI, it would be best to prevent HBV reactivation which inhibits the development of hepatitis and subsequent mortality. In diverse cases with insufficient data to recommend routine prophylaxis, early identification of virologic reactivation is essential to start antiviral therapy. For retrieving articles regarding OBI, various databases, including OVID, PubMed, Scopus, and ScienceDirect, were used.

摘要

隐匿性乙型肝炎病毒感染(OBI)的定义为,在HBsAg阴性、有或无既往病毒暴露血清学标志物的患者中,通过敏感诊断检测在血清或肝脏中检测到HBV DNA。在乙型肝炎病毒感染高危和患有肝病的人群中,隐匿性乙型肝炎病毒感染似乎更为常见。隐匿性乙型肝炎病毒感染既可能是血液和器官捐献中病毒污染的来源,也可能是病毒再激活后发生严重肝炎的病毒储存库。乙肝病毒再激活取决于病毒和宿主因素,但这些关联尚未得到充分分析。对于隐匿性乙型肝炎病毒感染,最好预防乙肝病毒再激活,因为这可以抑制肝炎的发展及随后的死亡率。在缺乏足够数据推荐常规预防措施的各种情况下,早期识别病毒学再激活对于启动抗病毒治疗至关重要。为检索有关隐匿性乙型肝炎病毒感染的文章,我们使用了包括OVID、PubMed、Scopus和ScienceDirect在内的各种数据库。

相似文献

1
Occult hepatitis B: clinical viewpoint and management.隐匿性乙型肝炎:临床观点与管理
Hepat Res Treat. 2013;2013:259148. doi: 10.1155/2013/259148. Epub 2013 Mar 4.
2
Management of occult hepatitis B virus infection: an update for the clinician.隐匿性乙型肝炎病毒感染的管理:临床医生的最新进展。
World J Gastroenterol. 2011 Mar 28;17(12):1563-8. doi: 10.3748/wjg.v17.i12.1563.
3
[Occult hepatitis B virus infection: transmission and reactivation].[隐匿性乙型肝炎病毒感染:传播与再激活]
Korean J Gastroenterol. 2013 Sep;62(3):148-53. doi: 10.4166/kjg.2013.62.3.148.
4
Evolution of the serologic and virologic course of occult HBV infection in therapy experienced HIV co-infected patients.在有治疗史的 HIV 合并感染患者中,隐匿性乙型肝炎病毒感染的血清学和病毒学进程的演变。
J Med Virol. 2018 Feb;90(2):291-303. doi: 10.1002/jmv.24956. Epub 2017 Nov 13.
5
Occult hepatitis B virus infection: detection and significance.隐匿性乙型肝炎病毒感染:检测与意义。
Dig Dis. 2010;28(1):116-25. doi: 10.1159/000282074. Epub 2010 May 7.
6
Prevalence and chemotherapy-induced reactivation of occult hepatitis B virus among hepatitis B surface antigen negative patients with diffuse large B-cell lymphoma: significance of hepatitis B core antibodies screening.乙肝表面抗原阴性的弥漫性大B细胞淋巴瘤患者中隐匿性乙型肝炎病毒的流行情况及化疗诱导的再激活:乙肝核心抗体筛查的意义
J Egypt Natl Canc Inst. 2015 Mar;27(1):11-8. doi: 10.1016/j.jnci.2015.01.004. Epub 2015 Feb 21.
7
Quantitation of HBV cccDNA in anti-HBc-positive liver donors by droplet digital PCR: A new tool to detect occult infection.利用液滴数字 PCR 定量检测抗-HBc 阳性肝供体中的 HBV cccDNA:一种检测隐匿性感染的新工具。
J Hepatol. 2018 Aug;69(2):301-307. doi: 10.1016/j.jhep.2018.03.021. Epub 2018 Apr 3.
8
Low prevalence of occult hepatitis B virus infection in chronic haemodialysis and kidney transplant patients.慢性血液透析和肾移植患者隐匿性乙型肝炎病毒感染的低发生率。
Liver Int. 2019 Feb;39(2):263-270. doi: 10.1111/liv.13951. Epub 2018 Oct 8.
9
Occult hepatitis B virus infection in patients with chronic hepatitis C treated with antiviral therapy.接受抗病毒治疗的慢性丙型肝炎患者中的隐匿性乙型肝炎病毒感染
Hepat Mon. 2012 Nov;12(11):e7292. doi: 10.5812/hepatmon.7292. Epub 2012 Nov 30.
10
Occult hepatitis B virus infection.隐匿性乙型肝炎病毒感染
World J Hepatol. 2014 Dec 27;6(12):860-9. doi: 10.4254/wjh.v6.i12.860.

引用本文的文献

1
Acute Hepatitis B Infection in a Patient With Confirmed Immunity on Long-Acting Cabotegravir/Rilpivirine.使用长效卡博特韦/利匹韦林确认具有免疫力的患者发生急性乙型肝炎感染
ACG Case Rep J. 2024 Dec 27;12(1):e01575. doi: 10.14309/crj.0000000000001575. eCollection 2025 Jan.
2
Serologic screening for viral infections among blood donors: a study in a blood bank in southern Brazil.献血者病毒感染血清学筛查:巴西南部一家血库的研究。
Rev Assoc Med Bras (1992). 2024 Sep 2;70(8):e20240452. doi: 10.1590/1806-9282.20240452. eCollection 2024.
3
Prevalence of hepatitis B virus core antibodies among blood donors in Nigeria: Implications for blood safety.尼日利亚献血者中乙肝病毒核心抗体的流行情况:对血液安全的影响。
Afr J Lab Med. 2022 Jul 26;11(1):1434. doi: 10.4102/ajlm.v11i1.1434. eCollection 2022.
4
High resolution HLA-DRB1 analysis and shared molecular amino acid signature of DRβ1 molecules in Occult hepatitis B infection.隐匿性乙型肝炎感染中高分辨率 HLA-DRB1 分析和 DRβ1 分子的共享分子氨基酸特征。
BMC Immunol. 2022 Apr 25;23(1):22. doi: 10.1186/s12865-022-00496-2.
5
A Study of Prevalence of Occult Hepatitis B Virus Infection, Knowledge and Preventive Practices Against Hepatitis B Virus in Barbers Serving the Armed Forces.为军队服务的理发师中隐匿性乙型肝炎病毒感染的流行情况、对乙型肝炎病毒的认知及预防措施研究
J Clin Exp Hepatol. 2021 Nov-Dec;11(6):668-673. doi: 10.1016/j.jceh.2021.02.005. Epub 2021 Feb 20.
6
Cytokine profile during occult hepatitis B virus infection in chronic hepatitis C patients.隐匿性乙型肝炎病毒感染慢性丙型肝炎患者的细胞因子谱。
Virol J. 2021 Jan 12;18(1):15. doi: 10.1186/s12985-021-01487-2.
7
Hepatitis B virus infection: Defective surface antigen expression and pathogenesis.乙型肝炎病毒感染:表面抗原表达缺陷与发病机制。
World J Gastroenterol. 2018 Aug 21;24(31):3488-3499. doi: 10.3748/wjg.v24.i31.3488.
8
Genetic polymorphisms of HLA-DP and isolated anti-HBc are important subsets of occult hepatitis B infection in Indonesian blood donors: a case-control study.HLA-DP 基因多态性和单独的抗-HBc 是印度尼西亚献血者隐匿性乙型肝炎感染的重要亚群:一项病例对照研究。
Virol J. 2017 Oct 23;14(1):201. doi: 10.1186/s12985-017-0865-7.
9
Platelet counts modulate the quantitative relationship between hepatitis B viral DNA and surface antigen concentrations: a cross-sectional study of hematological, histological and viral factors.血小板计数调节乙肝病毒DNA与表面抗原浓度之间的定量关系:血液学、组织学和病毒学因素的横断面研究
BMC Infect Dis. 2017 Jan 5;17(1):9. doi: 10.1186/s12879-016-2121-y.
10
High-dose hepatitis B immunoglobulin therapy in hepatocellular carcinoma with hepatitis B virus-DNA/hepatitis B e antigen-positive patients after living donor liver transplantation.活体肝移植后乙肝病毒DNA/乙肝e抗原阳性肝细胞癌患者的大剂量乙肝免疫球蛋白治疗
World J Gastroenterol. 2016 Apr 14;22(14):3803-12. doi: 10.3748/wjg.v22.i14.3803.

本文引用的文献

1
Occult hepatitis B virus and the risk for chronic liver disease: a meta-analysis.隐匿性乙型肝炎病毒与慢性肝病风险:荟萃分析。
Dig Liver Dis. 2013 Mar;45(3):238-44. doi: 10.1016/j.dld.2012.09.021. Epub 2012 Nov 10.
2
Occult HBV infection.隐匿性乙型肝炎病毒感染。
Semin Immunopathol. 2013 Jan;35(1):39-52. doi: 10.1007/s00281-012-0327-7. Epub 2012 Jul 26.
3
Epidemiology of viral hepatitis and hepatocellular carcinoma.病毒性肝炎与肝细胞癌的流行病学。
Gastroenterology. 2012 May;142(6):1264-1273.e1. doi: 10.1053/j.gastro.2011.12.061.
4
T cell responses and viral variability in blood donation candidates with occult hepatitis B infection.隐匿性乙型肝炎感染献血者的 T 细胞反应和病毒变异性。
J Hepatol. 2012 Apr;56(4):765-74. doi: 10.1016/j.jhep.2011.11.011. Epub 2011 Dec 13.
5
Reactivation of resolved hepatitis B virus infection after immunosuppression: is it time to adopt pre-emptive therapy?免疫抑制后已解决的乙型肝炎病毒感染再激活:是否是时候采用抢先治疗?
Clin Res Hepatol Gastroenterol. 2012 Feb;36(1):84-93. doi: 10.1016/j.clinre.2011.07.018. Epub 2011 Sep 14.
6
Occult hepatitis B infection and HBV replicative activity in patients with cryptogenic cause of hepatocellular carcinoma.隐匿性乙型肝炎感染和乙型肝炎病毒复制活性与不明原因的肝细胞癌患者。
Hepatology. 2011 Sep 2;54(3):829-36. doi: 10.1002/hep.24551. Epub 2011 Jul 21.
7
Association between occult hepatitis B infection and the risk of hepatocellular carcinoma: a meta-analysis.隐匿性乙型肝炎感染与肝细胞癌风险的关系:一项荟萃分析。
Liver Int. 2012 Feb;32(2):231-40. doi: 10.1111/j.1478-3231.2011.02481.x. Epub 2011 Feb 23.
8
Hepatitis B virus reactivation in patients receiving cancer chemotherapy: natural history, pathogenesis, and management.接受癌症化疗患者的乙型肝炎病毒再激活:自然史、发病机制及管理
Hepatol Int. 2013 Jun;7(2):316-26. doi: 10.1007/s12072-011-9279-6. Epub 2011 Jun 14.
9
Management of occult hepatitis B virus infection: an update for the clinician.隐匿性乙型肝炎病毒感染的管理:临床医生的最新进展。
World J Gastroenterol. 2011 Mar 28;17(12):1563-8. doi: 10.3748/wjg.v17.i12.1563.
10
Diagnostic strategy for occult hepatitis B virus infection.隐匿性乙型肝炎病毒感染的诊断策略。
World J Gastroenterol. 2011 Mar 28;17(12):1553-7. doi: 10.3748/wjg.v17.i12.1553.